Treatment of Alzheimer's Disease
Alzheimer's disease is the most common cause of dementia — a progressive neurological disorder that destroys memory and other cognitive functions. It typically begins with mild memory loss and progresses to severe cognitive impairment.
Managing Alzheimer's Disease effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Alzheimer's Disease can maintain a good quality of life and prevent serious complications.
First-Line Treatment Principles
- ✓Accurate diagnosis essential: neuroimaging (MRI preferred), EEG, CSF analysis as indicated
- ✓Monotherapy preferred for epilepsy before combination; balance efficacy vs. teratogenicity
- ✓Early migraine prophylaxis if >4 headache days/month or significant disability
- ✓Levodopa remains gold standard for Parkinson's motor symptoms
- ✓Stroke: thrombolysis within 4.5h; thrombectomy up to 24h in selected patients; early secondary prevention
What to Do Now
- Learn your personal risk factors for Alzheimer's Disease (family history, age, lifestyle)
- Attend regular health check-ups and screening tests appropriate for your age and risk
- Track new or changing symptoms, especially those associated with Alzheimer's Disease
- Use our AI symptom checker to assess whether your symptoms fit an early Alzheimer's Disease pattern
- Discuss preventive strategies and early monitoring with your GP
- Build a personalised management plan with your GP or specialist
- Adhere consistently to prescribed medications — do not stop without medical advice
- Adopt a Alzheimer's Disease-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)
Medications Used in Alzheimer's Disease
Donepezil is a cholinesterase inhibitor that improves cognitive function in Alzheimer's disease and other dementias by increasing acetylcholine levels.
Rivastigmine is a cholinesterase inhibitor that improves cognitive function in Alzheimer's disease and other dementias by increasing acetylcholine levels.
Galantamine is a cholinesterase inhibitor that improves cognitive function in Alzheimer's disease and other dementias by increasing acetylcholine levels.
Memantine is a cholinesterase inhibitor that improves cognitive function in Alzheimer's disease and other dementias by increasing acetylcholine levels.
Non-Pharmacological Management
- •Lifestyle triggers: identify and avoid migraine triggers (irregular sleep, skipped meals, alcohol, bright light)
- •Sleep hygiene: critical for epilepsy control and migraine management
- •Physiotherapy and occupational therapy: for Parkinson's, post-stroke rehabilitation, multiple sclerosis
- •Speech and language therapy: post-stroke, Parkinson's, ALS
- •Cognitive rehabilitation for dementia and post-stroke cognitive impairment
- •Seizure first aid education for patients and carers
- •Mediterranean diet: associated with reduced dementia risk and improved post-stroke outcomes
Treatment Goals
Monitoring Parameters
- ◆Seizure diary: frequency, type, duration — key for epilepsy drug titration
- ◆Cognitive function: MMSE/MoCA annually in dementia and Parkinson's
- ◆Motor function scales: UPDRS for Parkinson's; EDSS for MS; mRS for stroke
- ◆Drug levels: essential for phenytoin, carbamazepine, valproate — and lithium in psychiatric comorbidity
- ◆MRI: new or progressive neurological symptoms; MS disease activity monitoring
- ◆LFTs, FBC: valproate (hepatotoxicity, thrombocytopenia); carbamazepine (agranulocytosis)
Red Flags — When to Escalate
- ⚠Any of the characteristic symptoms of Alzheimer's Disease — even mild — in a high-risk individual
- ⚠Progressive worsening of early warning signs over weeks
- ⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
- ⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
- ⚠Strong family history of Alzheimer's Disease combined with new relevant symptoms
- ⚠Sudden worsening of Alzheimer's Disease symptoms despite established treatment
Escalation Criteria
- →Status epilepticus: IV benzodiazepine, then anti-epileptic loading dose; ICU if refractory
- →Parkinson's motor fluctuations despite optimised oral therapy → LCIG, DBS, or apomorphine infusion consideration
- →MS relapse: high-dose IV methylprednisolone; assess for disease-modifying therapy escalation
- →Acute severe migraine / thunderclap headache → exclude subarachnoid haemorrhage (CT + LP)
Special Populations
Clinical Insights
Compare With Similar Conditions
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →